EcoR1 Capital, LLC
- SEC CIK
- 0001587114
- 最新申報
- 2026/8/14
2021 年第 2 季持倉
持倉截至 2021/6/30，2021/8/16 申報。只含多頭部位，變化是跟 2021 年第 1 季比股數。
- 持股檔數
- 72
- 較 2021 年第 1 季 +2
- 總值
- $26.6 億
- 較 2021 年第 1 季 +$4.31 億 (+19.3%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| PRTAProthena Corp Public Ltd Co | SHS | 11,284,280 | $5.80 億 | 21.8% | +250,000+2.3% | 加碼 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 3,951,566 | $2.27 億 | 8.5% | +952,251+31.7% | 加碼 | 歷史 |
| ANABAnaptysbio, Inc | COM | 7,521,024 | $1.95 億 | 7.3% | +369,400+5.2% | 加碼 | 歷史 |
| XNCRXencor Inc | COM | 4,906,106 | $1.69 億 | 6.4% | +5,800+0.1% | 加碼 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 4,487,776 | $1.64 億 | 6.2% | +1,058,413+30.9% | 加碼 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 13,711,517 | $1.28 億 | 4.8% | +464,500+3.5% | 加碼 | 歷史 |
| STTKShattuck Labs, Inc. | COM | 3,318,410 | $9,620 萬 | 3.6% | +860,151+35.0% | 加碼 | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 3,335,247 | $9,159 萬 | 3.4% | +1,139,355+51.9% | 加碼 | 歷史 |
| ALECAlector, Inc. | COM | 4,242,634 | $8,837 萬 | 3.3% | +3,640,034+604.1% | 加碼 | 歷史 |
| SPRYARS Pharmaceuticals, Inc. | COM | 2,618,036 | $8,087 萬 | 3.0% | +84,401+3.3% | 加碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 3,724,437 | $7,766 萬 | 2.9% | +31,800+0.9% | 加碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 464,298 | $7,500 萬 | 2.8% | 00.0% | 不變 | 歷史 |
| ORICOric Pharmaceuticals, Inc. | COM | 3,092,218 | $5,470 萬 | 2.1% | 00.0% | 不變 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 1,967,950 | $5,221 萬 | 2.0% | −51,069−2.5% | 減碼 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 2,103,950 | $5,199 萬 | 2.0% | 00.0% | 不變 | – |
| JANXJanux Therapeutics, Inc. | COM | 1,411,975 | $3,523 萬 | 1.3% | +1,411,975 | 新進 | 歷史 |
| SLDBSolid Biosciences Inc. | COM | 9,202,702 | $3,368 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| GRTSGritstone bio, Inc. | COM | 3,421,287 | $3,124 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| Translate Bio, Inc.89374L104 | COM | 1,048,976 | $2,889 萬 | 1.1% | +452,076+75.7% | 加碼 | – |
| ITOSiTeos Therapeutics, Inc. | COM | 1,035,864 | $2,657 萬 | 1.0% | +775,864+298.4% | 加碼 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 1,224,175 | $2,611 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 519,416 | $2,519 萬 | 0.9% | +419,416+419.4% | 加碼 | 歷史 |
| DSGNDesign Therapeutics, Inc. | COM | 1,260,019 | $2,506 萬 | 0.9% | +122,079+10.7% | 加碼 | 歷史 |
| AKUSAkouos, Inc. | COM | 1,975,984 | $2,480 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| ARVNArvinas, Inc. | COM | 321,724 | $2,477 萬 | 0.9% | +3,020+0.9% | 加碼 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 6,082,200 | $2,378 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| NGNENeurogene Inc. | COM | 2,358,804 | $2,177 萬 | 0.8% | −763,900−24.5% | 減碼 | 歷史 |
| ACIUAC Immune SA | SHS | 2,648,163 | $2,100 萬 | 0.8% | −1,000,000−27.4% | 減碼 | 歷史 |
| BCELAtreca, Inc. | CL A COM | 2,426,685 | $2,068 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 754,545 | $1,676 萬 | 0.6% | +754,545 | 新進 | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 931,650 | $1,316 萬 | 0.5% | −318,351−25.5% | 減碼 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 200,000 | $1,064 萬 | 0.4% | +200,000 | 新進 | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 3,579,377 | $955.7 萬 | 0.4% | +3,579,377 | 新進 | 歷史 |
| KRONKronos Bio, Inc. | COM | 387,357 | $927.7 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| BCTG Acquisition Corp05492W103 | COM | 800,000 | $910.4 萬 | 0.3% | 00.0% | 不變 | – |
| KLRSKalaris Therapeutics, Inc. | COM | 447,012 | $882.4 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CCCCC4 Therapeutics, Inc. | COM STK | 200,000 | $756.8 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| KRSAKorsana Biosciences, Inc. | COM | 1,606,276 | $626.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 100,000 | $602.5 萬 | 0.2% | +100,000 | 新進 | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM | 1,000,000 | $545.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| JYACJiya Acquisition Corp. | COM CL A | 500,000 | $497.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 522,635 | $470.4 萬 | 0.2% | −218,655−29.5% | 減碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 215,000 | $452.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 400,000 | $408.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 366,867 | $358.8 萬 | 0.1% | −189,487−34.1% | 減碼 | 歷史 |
| IGMSIGM Biosciences, Inc. | COM | 38,030 | $316.4 萬 | 0.1% | +38,030 | 新進 | 歷史 |
| ODTOdonate Therapeutics, Inc. | COM | 831,200 | $290.1 萬 | 0.1% | +831,200 | 新進 | 歷史 |
| NGMNGM Biopharmaceuticals Inc | COM | 143,567 | $283.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 105,638 | $262.9 萬 | 0.1% | +105,638 | 新進 | 歷史 |
| BOLTBolt Biotherapeutics, Inc. | COM | 150,000 | $231.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| BCABBioAtla, Inc. | COM | 50,000 | $211.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| BCLS Acquisition CorpG0904B105 | COM CL A | 200,000 | $210.6 萬 | 0.1% | 00.0% | 不變 | – |
| MLTXMoonLake Immunotherapeutics | COM CL A | 200,000 | $207.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| 5 01 Acquisition Corp33836P105 | COM CL A | 200,000 | $199.4 萬 | 0.1% | 00.0% | 不變 | – |
| Consonance HFW Acquisition CG2445M103 | SHS CL A | 200,000 | $198.7 萬 | 0.1% | +200,000 | 新進 | – |
| Eucrates Biomedical Acqu CorG3141W106 | SHS | 200,000 | $196.9 萬 | 0.1% | 00.0% | 不變 | – |
| FLACFrazier Lifesciences Acquisition Corp | CL A SHS | 200,495 | $195.7 萬 | 0.1% | +200,495 | 新進 | 歷史 |
| PMVPPMV Pharmaceuticals, Inc. | COM | 50,000 | $170.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 150,000 | $160.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 50,000 | $155.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| FS Development Corp II30318F100 | COM CL A | 150,000 | $149.7 萬 | 0.1% | 00.0% | 不變 | – |
| MGTXMeiraGTx Holdings plc | COM | 94,819 | $147.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CareMax, Inc.14171W111 | *W EXP 06/08/202 | 100,000 | $129.0 萬 | <0.1% | +100,000 | 新進 | – |
| Turmeric Acquisition CorpG9127T108 | CL A | 100,000 | $98.9 萬 | <0.1% | 00.0% | 不變 | – |
| KNTEKinnate Biopharma Inc. | COM | 25,000 | $58.2 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Omega Alpha SpacG6749V107 | CL A | 50,000 | $49.8 萬 | <0.1% | 00.0% | 不變 | – |
| FSTXF-star Therapeutics, Inc. | COM | 46,000 | $39.5 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 963,333 | – | – | 00.0% | 不變 | – |
| Consonance HFW Acquisition CG2445M111 | *W EXP 10/28/202 | 66,665 | – | – | +66,665 | 新進 | – |
| Eucrates Biomedical Acqu CorG3141W122 | *W EXP 10/23/202 | 66,666 | – | – | 00.0% | 不變 | – |
| Frazier Lifesciences Acqu CoG3710A113 | *W EXP 11/30/202 | 66,665 | – | – | +66,665 | 新進 | – |
| Turmeric Acquisition CorpG9127T124 | *W EXP 10/08/202 | 33,333 | – | – | 00.0% | 不變 | – |
2021 年第 1 季之後清倉（11 檔）
2021 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 1 季股數 | 2021 年第 1 季市值 | 2021 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ELDNEledon Pharmaceuticals, Inc. | COM | 1,115,721 | $1,194 萬 | 0.5% | 歷史 |
| AMTIApplied Molecular Transport Inc. | COM | 239,443 | $1,054 萬 | 0.5% | 歷史 |
| LogicBio Therapeutics, Inc.54142F102 | COM | 688,700 | $501.4 萬 | 0.2% | – |
| WHWKWhitehawk Therapeutics, Inc. | COM | 2,072,782 | $267.4 萬 | 0.1% | 歷史 |
| Frazier Lifesciences Acqu CoG3710A121 | UNIT 12/09/2025 | 200,000 | $203.2 萬 | 0.1% | – |
| Consonance HFW Acquisition CG2445M129 | UNIT 99/99/9999 | 200,000 | $195.2 萬 | 0.1% | – |
| CDAKCodiak BioSciences, Inc. | COM | 115,195 | $173.7 萬 | 0.1% | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 56,500 | $57.3 萬 | <0.1% | 歷史 |
| MTCRMetacrine, Inc. | COM | 62,207 | $38.6 萬 | <0.1% | 歷史 |
| Deerfield Healthcare Tech Ac244413118 | *W EXP 07/16/202 | 100,000 | – | – | – |
| Vincerx Pharma, Inc.92731L114 | *W EXP 12/24/202 | 150,000 | – | – | – |